Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

NCT06621602 is registered in ClinicalTrials.gov with CND Life Sciences as lead sponsor.

NCT NCT06621602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
Lead sponsor
CND Life Sciences
Phase
Observational
Overall status
Active, not recruiting
Start date
December 17, 2024
Completion date
April 30, 2027
Enrollment
100 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, rem behavior disorder